drugset / Trial / NCT04924322

Summary

The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.

Timeline

Start
2022-05-11
Primary completion
2027-04-30
Completion
2027-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 0.5 mg/kg
Subject Enoxaparin sodium Other / unclassified 1.5 mg/kg

Indications